EyePoint Pharmaceuticals Inc (EYPT)
8.99
-0.18
(-1.96%)
USD |
NASDAQ |
Nov 18, 12:42
EyePoint Pharmaceuticals Price: 8.99 for Nov. 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 15, 2024 | 10.56 | 10.56 | 9.05 | 9.17 | 1.017M |
| Nov 14, 2024 | 10.80 | 10.83 | 10.26 | 10.49 | 794973.0 |
| Nov 13, 2024 | 11.29 | 11.38 | 10.46 | 10.76 | 739226.0 |
| Nov 12, 2024 | 11.86 | 11.97 | 11.09 | 11.11 | 630593.0 |
| Nov 11, 2024 | 11.73 | 12.23 | 11.64 | 12.00 | 548158.0 |
| Nov 08, 2024 | 11.59 | 11.77 | 11.26 | 11.63 | 537131.0 |
| Nov 07, 2024 | 12.41 | 12.50 | 11.35 | 11.59 | 717631.0 |
| Nov 06, 2024 | 11.99 | 12.37 | 11.76 | 12.08 | 757558.0 |
| Nov 05, 2024 | 11.53 | 11.71 | 11.06 | 11.61 | 417507.0 |
| Nov 04, 2024 | 12.06 | 12.10 | 11.30 | 11.70 | 803075.0 |
| Nov 01, 2024 | 11.88 | 12.47 | 11.31 | 12.06 | 839280.0 |
| Oct 31, 2024 | 11.28 | 12.09 | 10.96 | 11.76 | 1.436M |
| Oct 30, 2024 | 11.41 | 12.36 | 10.90 | 11.46 | 4.495M |
| Oct 29, 2024 | 12.02 | 12.75 | 11.14 | 11.54 | 1.688M |
| Oct 28, 2024 | 10.68 | 13.98 | 10.35 | 12.12 | 4.566M |
| Oct 25, 2024 | 9.59 | 9.78 | 9.23 | 9.50 | 375049.0 |
| Oct 24, 2024 | 10.10 | 10.17 | 9.54 | 9.56 | 281314.0 |
| Oct 23, 2024 | 10.61 | 10.75 | 9.70 | 9.96 | 568949.0 |
| Oct 22, 2024 | 10.67 | 10.91 | 10.47 | 10.75 | 302940.0 |
| Oct 21, 2024 | 11.03 | 11.20 | 10.50 | 10.70 | 418734.0 |
| Oct 18, 2024 | 11.22 | 11.46 | 10.84 | 11.05 | 477721.0 |
| Oct 17, 2024 | 11.20 | 11.35 | 10.94 | 11.15 | 519928.0 |
| Oct 16, 2024 | 9.93 | 11.37 | 9.91 | 11.28 | 1.116M |
| Oct 15, 2024 | 10.17 | 10.47 | 9.57 | 9.88 | 820256.0 |
| Oct 14, 2024 | 8.92 | 10.30 | 8.822 | 10.17 | 1.071M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.28
Minimum
Mar 24 2023
29.71
Maximum
Feb 12 2024
10.21
Average
9.30
Median
Mar 29 2021
Price Benchmarks
| Cassava Sciences Inc | 27.23 |
| Regeneron Pharmaceuticals Inc | 757.30 |
| Adverum Biotechnologies Inc | 7.02 |
| Regenxbio Inc | 10.40 |
| Editas Medicine Inc | 2.565 |
Price Related Metrics
| PS Ratio | 9.969 |
| Price to Book Value | 2.805 |
| Earnings Yield | -22.14% |
| Market Cap | 613.58M |